FOXO3 and cardiac hypertrophy: In the present study, the FOXO3–SOD2‐mediated antioxidative effects were significantly enhanced in CD38 knockdown in H9c2 cells, further demonstrating that the protection of CD38 deficiency on cardiac hypertrophy induced by Ang‐II was consistent with our previous findings.